EGFR is overexpressed in most epithelial cell carcinomas such as colorectal cancer, breast cancer, and lung cancer, and it is known that activation of EGFR promotes cancer proliferation, angiogenesis, metastasis and inhibits apoptosis [44]. Here, EGFR is linked to lung carcinoma.